Chemoreduction for Group E Retinoblastoma: Comparison of Chemoreduction Alone Versus Chemoreduction Plus Low-Dose External Radiotherapy in 76 Eyes

Ophthalmology

Volumn 116, Issue 3, 2009, Pages

  Shields, Carol L ^a   Ramasubramanian, Aparna ^a   Thangappan, Archana ^a   Hartzell, Kimberly ^a   Leahey, Ann ^b   Meadows, Anna T ^b   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; ENUCLEATION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; INFANT; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; PINEAL BODY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RETINOBLASTOMA; RETROSPECTIVE STUDY; SALVAGE THERAPY; SECOND CANCER; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY;

EID: 61349184336     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.10.014     Document Type: Article

References (15)

1. Shields C.L., Meadows A.T., Leahey A.M., and Shields J.A. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina 24 (2004) 849-862
2. Shields J.A., and Shields C.L. Intraocular Tumors: An Atlas and Textbook. 2nd ed. (2008), Lippincott Williams & Wilkins, Philadelphia 334-351
3. Shields C.L., Mashayekhi A., Au A.K., et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 113 (2006) 2276-2280
4. Shields C.L., and Shields J.A. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 17 (2006) 228-234
5. Olson M.R., and Donaldson S.S. Treatment of pediatric Hodgkin lymphoma. Curr Treat Options Oncol 9 (2008) 81-94
6. Chow L.M., Nathan P.C., Hodgson D.C., et al. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation. J Clin Oncol 24 (2006) 5735-5741
7. Shields C.L., Honavar S.G., Meadows A.T., et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 133 (2002) 657-664
8. Murphree A.L. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 18 (2005) 41-53 viii
9. Gunduz K., Gunalp I., Yalcindag N., et al. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to treatment with external beam radiotherapy and enucleation. Ophthalmology 111 (2004) 1917-1924
10. Gunduz K., Shields C.L., Shields J.A., et al. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma. Arch Ophthalmol 116 (1998) 1613-1617
11. Abramson D.H., Beaverson K.L., Chang S.T., et al. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth Group Vb retinoblastoma. Arch Ophthalmol 122 (2004) 1316-1323
12. Kingston J.E., Hungerford J.L., Madreperla S.A., and Plowman P.N. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 114 (1996) 1339-1343
13. Abramson D.H., and Frank C.M. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 105 (1998) 573-579
14. Kleinerman R.A., Tucker M.A., Abramson D.H., et al. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst 99 (2007) 24-31
15. Wong F.L., Boice Jr. J.D., Abramson D.H., et al. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA 278 (1997) 1262-1267